Poster Presentation at the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC):

• A Randomized Controlled Phase II Clinical Trial Demonstrating the Efficacy of Topical Nanoemulsions (NB-001)for the Treatment of Herpes Labialis

Poster Presentation at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Poster Presentation M-1819:

• Antifungal Drugs Tolerability, Safety and Pharmacokinetics of Topical Nanoemulsions (NB-002) in Patients with Onychomycosis

Poster Presentations at the 66th Annual Meeting of The American Academy of Dermatology (AAD), San Antonio, Texas, February 1 - 4, 2008.

• Poster # 1801: Safety, Tolerance, Pharmacokinetics and Efficacy of Topical Nanoemulsion (NB-001) for the Treatment of Herpes Labialis. 

• Poster # 1410: Safety, Tolerance, and Pharmacokinetics of Topical Nanoemulsion (NB-002) for the Treatment of Onychomycosis. 

• Poster # 1815: Development of a Novel Antiviral Drug (NB-001) for Topical Application in Humans. 

• Poster # 1709: Development of a Novel Topically Applied Antifungal Agent (NB-002) Based on Nanoemulsion Technology.